Dr. Peden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
602 S Macdill Ave
Tampa, FL 33609Phone+1 813-875-6373Fax+1 813-876-0960
Education & Training
University of FloridaResidency, Ophthalmology, 2004 - 2007- University of FloridaInternship, Internal Medicine, 2003 - 2004
- University of Florida College of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2006 - 2026- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 485 citationsGene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 yearsSamuel G. Jacobson, Artur V. Cideciyan, R. Ratnakaram, Elise Héon, Sharon B. Schwartz
Archives of Ophthalmology. 2012-01-09 - 74 citationsPreclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.Thomas J. Conlon, Wen-Tao Deng, Kirsten E. Erger, Travis Cossette, Jijing Pang
Human Gene Therapy. Clinical Development. 2013-03-08 - 5 citationsVariegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.Jason Charng, Artur V Cideciyan, Samuel G Jacobson, Alexander Sumaroka, Sharon B Schwartz
Human Molecular Genetics. 2019-01-01
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
